| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/30/2011 | WO2011076880A1 Methods and use related to humanin and humanin-like peptides |
| 06/30/2011 | WO2011076854A1 CLEAVAGE OF β-AMYLOID PRECURSOR PROTEIN |
| 06/30/2011 | WO2011076781A1 Tetravalent cd47-antibody constant region fusion protein for use in therapy |
| 06/30/2011 | WO2011076702A1 Pharmaceutical compositions comprising igf-1 proteins, a buffering and a tonicity agent |
| 06/30/2011 | WO2011076123A1 Compositions comprising boosting polypeptide and starch degrading enzyme and uses thereof |
| 06/30/2011 | WO2011076117A1 Compositions of menopausal gonadotrophins |
| 06/30/2011 | WO2011076095A1 Methods and compositions related to reduced met phosphorylation by leukocyte cell-derived chemotaxin 2 in tumor cells |
| 06/30/2011 | WO2011076084A1 Novel gastric cancer biomarker and uses thereof |
| 06/30/2011 | WO2011060613A9 Human alpha-defensin 5 mutant polypeptide and preparation method and use thereof |
| 06/30/2011 | WO2011036442A3 Thrombin c- terminal polypeptides and uses thereof for treating inflammation coagulation disorders |
| 06/30/2011 | WO2011034659A3 Advantageous mu-opiate receptor peptide compounds |
| 06/30/2011 | WO2011031676A3 Depleting immunosuppressive monocytes within a mammal |
| 06/30/2011 | WO2011027980A9 Tumor cell-killing peptides |
| 06/30/2011 | WO2011027257A3 Pcsk9 vaccine |
| 06/30/2011 | WO2011019963A3 Prg4 treatment for interstitial cystitis |
| 06/30/2011 | WO2011011706A3 Methods and compositions for treating or preventing autoimmune diseases using immunomodulatory agents |
| 06/30/2011 | WO2010150982A3 Recombinant hemagglutinin protein having superior biocompatibility for an influenza virus vaccine, and method for preparing biodegradable plga microspheres containing same |
| 06/30/2011 | WO2010119088A3 Milk and milk-based products modified to exhibit a reduced insulinemic index and/or reduced mitogenic activity |
| 06/30/2011 | WO2007113540A8 Regulating fat and carbohydrate oxidation in muscle tissue comprising controlling carnitine content in muscle |
| 06/30/2011 | US20110162107 Plants having improved growth characteristics and methods for making the same |
| 06/30/2011 | US20110162095 TNFSF Single Chain Molecules |
| 06/30/2011 | US20110162094 Modified human factor vii/viia and pharmaceutical composition containing the same |
| 06/30/2011 | US20110162092 Composition comprised of akap12 and uses of akap12 mutant zebrafish as an animal model |
| 06/30/2011 | US20110160445 Heparin-Binding Growth Factor (HBGF) Polypeptides |
| 06/30/2011 | US20110160443 Rna aptamers and methods for identifying the same |
| 06/30/2011 | US20110160438 Il-17 receptor like molecules and uses thereof |
| 06/30/2011 | US20110160295 Antitumor agent |
| 06/30/2011 | US20110160291 Oligonucleotide Compositions and Their Use to Induce Apoptosis |
| 06/30/2011 | US20110160286 Allele-specific rna interference |
| 06/30/2011 | US20110160278 Methods For Selectively Modulating Survivin Apoptosis Pathways |
| 06/30/2011 | US20110160150 Thiol-containing compounds for the removal of elements from tissues and formulations therefor |
| 06/30/2011 | US20110160149 Pharmaceutical Composition for a Hepatitis C Viral Protease Inhibitor |
| 06/30/2011 | US20110160148 Novel Diverse Lead Compound Autotaxin Inhibitors |
| 06/30/2011 | US20110160147 Novel dual targeting antitumoral conjugates |
| 06/30/2011 | US20110160145 Treatment of fine wrinkles with clostridia neurotoxins |
| 06/30/2011 | US20110160143 Topical Acyl Glutathione Psoriasis Compositions |
| 06/30/2011 | US20110160142 Alpha B-Crystallin as a therapy for inflammation |
| 06/30/2011 | US20110160141 Neurotrophic Peptides |
| 06/30/2011 | US20110160140 Composition for improving brain function and method for improving brain function |
| 06/30/2011 | US20110160139 Composition for improving brain function and method for improving brain function |
| 06/30/2011 | US20110160138 Composition for improving brain function and method for improving brain function |
| 06/30/2011 | US20110160136 Polyphenols for the treatment of cartilage disorders |
| 06/30/2011 | US20110160135 Suppression of neuroendocrine diseases |
| 06/30/2011 | US20110160134 Device and Method for Making Solid Beads |
| 06/30/2011 | US20110160133 Method for inhibiting inflammation and pre-inflammatory cytokine/chemokine expression using a ghrelin analogue |
| 06/30/2011 | US20110160132 Lymphangiogenesis-promoting agents |
| 06/30/2011 | US20110160131 Growth Factor-Mimicking Peptides and Uses Thereof |
| 06/30/2011 | US20110160130 Cancer treatment method |
| 06/30/2011 | US20110160129 Therapeutic Agent Preparations for Delivery Into a Lumen of the Intestinal Tract Using a Swallowable Drug Delivery Device |
| 06/30/2011 | US20110160128 Corin for Treating Obesity and Diabetes |
| 06/30/2011 | US20110160127 Prodrugs of Neuraminidase Inhibitors |
| 06/30/2011 | US20110160126 Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders |
| 06/30/2011 | US20110160125 Method and culture medium for enhanced detection of mycobacterium |
| 06/30/2011 | US20110160124 Antimicrobial protein compositions and production therefor from marine bacteria |
| 06/30/2011 | US20110160123 Targeting the efflux systems of mycobacterium tuberculosis |
| 06/30/2011 | US20110160122 Polypeptides having Antimicrobial Activity and Polynucleotides Encoding Same |
| 06/30/2011 | US20110160121 Unacylated ghrelin and analogs as therapeutic agents for vascular remodeling in diabetic patients and treatment of cardiovascular disease |
| 06/30/2011 | US20110160120 Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders |
| 06/30/2011 | US20110160119 Anti-inflammatory compounds and uses thereof |
| 06/30/2011 | US20110160118 Methods and compositions for treating oral and esophageal lesions |
| 06/30/2011 | US20110159587 Chimeric Molecules to Modulate Gene Expression |
| 06/30/2011 | US20110159532 GEF-H1b: BIOMARKERS, COMPLEXES, ASSAYS AND THERAPEUTIC USES THEREOF |
| 06/30/2011 | US20110159131 Use of strains of lactobacillus and by-products thereof for inhibiting formation of blood vessels |
| 06/30/2011 | US20110159112 Recombinant alpha-fetoprotein and compositions thereof |
| 06/30/2011 | US20110159075 Compositions and systems for forming crosslinked biomaterials and methods of preparation and use |
| 06/30/2011 | US20110159071 Isolation and Identification of Glycosaminoglycans |
| 06/30/2011 | US20110159070 Biomaterials and implants for enhanced cartilage formation, and methods for making and using them |
| 06/30/2011 | US20110159069 Medical Implants and Methods of Making Medical Implants |
| 06/30/2011 | US20110159068 Osteogenic composition comprising a growth factor/amphiphilic polymer complex, a soluble cation salt and an organic support |
| 06/30/2011 | US20110159054 Nanoparticulate bicalutamide formulations |
| 06/30/2011 | US20110159052 Taxanes covalently bounded to hyaluronic acid or hyaluronic acid derivatives |
| 06/30/2011 | US20110159041 Chlamydia Trachomatis Genomic Sequence and Polypeptides, Fragments Thereof and Uses Thereof, in Particular for the Diagnosis, Prevention and Treatment of Infection |
| 06/30/2011 | US20110159034 Methods and reagents for vaccination which generate a cd8 t cell immune response |
| 06/30/2011 | US20110159016 Hemoglobin-based methods for prophylaxis, diagnosis and/or treatment of retinal disorders |
| 06/30/2011 | US20110159012 Method for isolating neural cells using tenascin-r compounds |
| 06/30/2011 | US20110159005 11-beta-hydroxysteroid dehydrogenase type 1 (11beta-hsd1) inhibitors and uses thereof |
| 06/30/2011 | US20110159004 Methods and Compositions for Preserving the Viability of Photoreceptor Cells |
| 06/30/2011 | US20110158993 Train-R: A Cysteine Rich Member of the TNF-Receptor Family |
| 06/30/2011 | US20110158983 Compositions and methods for mucositis and oncology therapies |
| 06/30/2011 | US20110158981 Methods and Compositions for Inhibiting Binding of IgE to a High Affinity Receptor |
| 06/30/2011 | US20110158980 Methods to treat and screen for agents to treat obesity |
| 06/30/2011 | US20110158977 Immunogenic compositions for Chlamydia trachomatis |
| 06/30/2011 | US20110158976 Enzymes for pharmaceutical use |
| 06/30/2011 | US20110158975 Use of runx3 and mir-532-5p as cancer markers and therapeutic targets |
| 06/30/2011 | US20110158974 Heterodimeric Meganucleases and Use Thereof |
| 06/30/2011 | US20110158973 Suppression of cancers |
| 06/30/2011 | US20110158972 Compositions and methods for treating collagen-mediated diseases |
| 06/30/2011 | US20110158971 Compositions comprising n3 alkylated benzimidazole derivatives as mek inhibitors and methods of use thereof |
| 06/30/2011 | US20110158968 Methods of making enhanced, autologous fat grafts |
| 06/30/2011 | US20110158958 Methods for treating ophthalmic disorders, diseases and injuries |
| 06/30/2011 | US20110158956 Treating cancer |
| 06/30/2011 | US20110158953 Tumor suppression through plexin c1 |
| 06/30/2011 | US20110158944 Braf biomarkers |
| 06/30/2011 | US20110158943 Interferon alpha 2b modified by polyethylene glycol, the preparation and use thereof |
| 06/30/2011 | US20110158942 Diaryl ureas for treating virus infections |
| 06/30/2011 | US20110158941 Crystalline recombinant interferon with altered spatial configuration, three-dimensional structure and uses thereof |
| 06/30/2011 | US20110158940 Samll molecule inhibitors for the treatment or prevention of dengue virus infection |
| 06/30/2011 | US20110158939 Methods and Compositions for Treating Asthma in Human and Nonhuman Primates |
| 06/30/2011 | US20110158938 Il-15 binding site for il 15-ralpha and specific il-15 mutants having agonists / antagonists activity |
| 06/30/2011 | US20110158937 Synergistic stimulation of the immune system using immunostimulatory oligonucleotides and/or immunomer compounds in conjunction with cytokines and/or chemotherapeutic agents or radiation therapy |